In a significant leap forward for India’s healthcare sector, pharmaceutical giant Cipla has inaugurated the country’s first fully dedicated lung diagnostics centre in New Delhi. The facility, known as the Breathefree Lung Wellness Center and located in Lajpat Nagar, aims to revolutionize how respiratory illnesses are detected, managed and treated across India.
Built as a comprehensive, one-stop destination for advanced lung diagnostics, the centre offers more than 60 specialised tests—making it one of the most extensive respiratory testing hubs in the nation. Patients can access cutting-edge investigative tools such as spirometry, oscillometry, DLCO tests, body plethysmography, FeNO assessments, cardiopulmonary exercise testing (CPET), alongside radiology services like X-rays and CT scans, sleep study facilities, and a wide range of microbiological and biochemical analyses.
These tests are crucial for early diagnosis and effective management of complex respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), lung fibrosis, bronchiectasis, and other progressive lung disorders. The availability of multiple diagnostic options under one roof ensures greater accuracy, faster detection and timely medical intervention.
Beyond diagnostics, the centre extends its services into holistic respiratory wellness. It provides pulmonary rehabilitation, nutritional counselling, smoking-cessation support, personalised breathing therapy, and several long-term health management programmes. This integrated approach ensures that patients not only receive a diagnosis but also continuous support throughout their recovery and lifestyle transformation.
Healthcare experts believe that Cipla’s initiative fills a long-standing gap in India’s respiratory-care infrastructure, especially at a time when pollution, lifestyle changes and post-viral complications have significantly increased the nation’s burden of lung disease. The Breathefree Lung Wellness Center promises to set new benchmarks in comprehensive lung care, offering hope and advanced medical support to millions of individuals dealing with respiratory challenges.
